172 results on '"Neufeld, E. J."'
Search Results
2. CDP/cut is the DNA-Binding Subunit of Histone Gene Transcription Factor HiNF-D: A Mechanism for Gene Regulation at the G$_{1}$/S Phase Cell Cycle Transition Point Independent of Transcription Factor E2F
3. Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices
4. Recombinant porcine factor VIII for high‐risk surgery in paediatric congenital haemophilia A with high‐titre inhibitor
5. Authorʼs response: ‘Transition considerations for extended half-life factor products’
6. Case study of two consanguineous brothers with type 3 von willebrand disease (VWD), inhibitors and anaphylactoid reaction to VWF: OR022
7. Transition considerations for extended half-life factor products
8. Correlation between dispensed and prescribed doses of factor products for bleeding disorders: can a small, centre-based pharmacy hit the mark?
9. Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg−1) rFVIIa doses across clinical trials and registries
10. Deletion of SLC19A2, the High Affinity Thiamine Transporter, Causes Selective Inner Hair Cell Loss and an Auditory Neuropathy Phenotype
11. Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE)
12. Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT
13. The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience
14. Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg−1 in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004–2008)
15. Quality of life in Thalassemia: A comparison of SF-36 results from the Thalassemia longitudinal cohort to reported literature and the US norms
16. Discordant haemophilia A in male siblings due to a de novo mutation on a familial missense mutant allele
17. Direct-to-consumer advertising for bleeding disorders: a content analysis and expert evaluation of advertising claims
18. Rituximab for adolescents with haemophilia and high titre inhibitors
19. Mechanisms for Eicosanoid Precursor Uptake and Release by a Tissue Culture Cell Line
20. Recognizing the need for personalization of haemophilia patient-reported outcomes in the prophylaxis era.
21. Recombinant activated factor VII in approved indications: Update on safety.
22. Safety of recombinant activated factor VII ( rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg−1) rFVIIa doses across clinical trials and registries.
23. Inflammatory bowel disease associated with immune thrombocytopenic purpura in children.
24. Inherited dyslipidemias in childhood.
25. Direct Measurement of LDL-C in Children: Performance of Two Surfactant-Based Methods in a General Pediatric Population
26. Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/cut homolog, is associated with histone deacetylation.
27. Preservation of arachidonoyl phospholipids during tissue processing for electron microscopic autoradiography.
28. CASP, a novel, highly conserved alternative-splicing product of the CDP/cut/cux gene, lacks cut-repeat and homeo DNA-binding domains, and interacts with full-length CDP in vitro
29. Sequence-specific DNA binding of individual cut repeats of the human CCAAT displacement/cut homeodomain protein.
30. Arachidonate release and phosphatidic acid turnover in stimulated human platelets.
31. Blockade of Selectin-Mediated Leukocyte Adhesion Improves Postischemic Function in Lamb Hearts
32. Uptake and subcellular distribution of [3H]arachidonic acid in murine fibrosarcoma cells measured by electron microscope autoradiography.
33. Mobility, clustering, and transport of nerve growth factor in embryonal sensory cells and in a sympathetic neuronal cell line.
34. A mutant HSDM1C1 fibrosarcoma line selected for defective eicosanoid precursor uptake lacks arachidonate-specific acyl-CoA synthetase.
35. Repressor activity of CCAAT displacement protein in HL-60 myeloid leukemia cells.
36. The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A
37. Regional Localization of the CCAAT Displacement Protein Gene (CUTL1) to 7q22 by Analysis of Somatic Cell Hybrids
38. A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia
39. Immunogenicity, efficacy and safety of Nuwiq ® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study.
40. Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
41. Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008).
42. Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice.
43. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies.
44. Characterization of a murine high-affinity thiamine transporter, Slc19a2.
45. Mechanism of thiamine uptake by human colonocytes: studies with cultured colonic epithelial cell line NCM460.
46. A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome.
47. Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport.
48. Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease.
49. The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A.
50. Homeoproteins CDP and SATB1 interact: potential for tissue-specific regulation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.